Clinical Trial Update: Dolutegravir-based Dual Therapies in HIV-infected Patients With Virological Suppression

View source ↗

Summary

Clinical trial update about switching virologically suppressed HIV patients to dolutegravir-based two-drug regimens; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Epivir (Lamivudine)
• Tivicay (dolutegravir)

Snippet

Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas | Conditions: HIV Infection | Status: COMPLETED